Hepatitis screening for migrants and refugees
Part of Digestive system, Infections clinical trials.
This study tests a quick blood test to check migrants and refugees for hepatitis B and D. It aims to find infections early so people can get the right care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a migrant, refugee, or asylum seeker
- You are 18 years or older
- You are receiving care at a participating infectious disease clinic
- You can give permission to take a blood sample and share basic health information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether people with both HIV and chronic hepatitis B should be checked for a third liver virus called HDV (hepatitis D). It helps find hidden infections so they can get the right care.
This study follows adults who have ongoing hepatitis D infection along with hepatitis B. It aims to better understand this mixed infection and how these patients do over time.
This trial tests a convenient way to screen people who use drugs or are in vulnerable situations for hepatitis B, C, and HIV using rapid tests and a liver scanner. The goal is to see if offering these tests in community settings (like shelters or mobile clinics) is acceptable and works well.
This study is looking for people in south-east Austria who have hepatitis B (HBV) or hepatitis C (HCV) that hasn't been fully treated or documented. It aims to find how many people also have hepatitis D (HDV) and are not yet aware of it.
This trial is testing treatments for people with chronic hepatitis D, a serious liver infection. If you have antibodies to the hepatitis D virus (HDV), you may be able to join and help find better ways to manage this condition.
This study looks at patient information (your health data) for adults who test positive for HDV. You may help researchers better understand HDV by allowing their team to collect and use your data.
Hear when a new Hepatitis D Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.